Laparoscopic sacrocolpopexy as the mainstay management for significant apical pelvic organ prolapse (LAP) study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F20%3A10410359" target="_blank" >RIV/00216208:11140/20:10410359 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/49777513:23640/20:43958779 RIV/00669806:_____/20:10410359
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Zok4swI4OL" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Zok4swI4OL</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejogrb.2019.10.049" target="_blank" >10.1016/j.ejogrb.2019.10.049</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Laparoscopic sacrocolpopexy as the mainstay management for significant apical pelvic organ prolapse (LAP) study
Popis výsledku v původním jazyce
Study objectives: The primary aim of this study was to assess the clinical feasibility of a policy where laparoscopic sacrocolpopexy (LSC) is the default procedure for the management of a significant apical pelvic organ prolapse (a-POP). As a secondary aim, we wanted to evaluate LSC outcomes in relation to women's preoperative assessment of their surgical fitness using the American Society of Anesthesiologists physical status (ASA-PS) categorization. Design: Retrospective cohort study. Setting: A university affiliated urogynecology center. Methods: All women with symptomatic a-POP (C >= -1) who attended the urogynecology clinic between the 1st of January and the 31st of December 2016 and had their surgery by the 31st of May 2017 were included in the study. In our unit, routine follow-up appointments are arranged at 3 and 12 months post LSC. Interventions: Perioperative and mesh-related complications were assessed based on the Dindo-Clavien and IUGA/ICS classifications respectively. The preoperative outcome measures included Pelvic Organ Prolapse Quantification (POP-Q) stage, Pelvic Floor Distress Inventory (PFDI) and ASA-PS score. At followup women were asked to complete a PFDI, Patient Global Impression of Improvement (PGI-1), had their POP-Qstaging and ultrasonographic assessment of mesh position and placement. The above measures are routinely collected as part of our standard practice. A preoperative ASA-PS score of <3 was used as a cut-off to dichotomies participants into low and high risk. Main results: A total of 220 women attended our center during the study period because of POP. Of these, 146 women were diagnosed with a significant a-POP and 142 (97.2 %) women opted for a surgical repair. Of the 142 women, 128 (90.1 %) were deemed suitable for a type of LSC and 121 had their surgery before the 31st of May 2017. There were no statistically significant differences in any of our collected perioperative, clinical, patient reported or ultrasonographic outcome measures when comparing women with ASA-PS scores of <3 or >= 3. Conclusion: In a specialized urogynecology healthcare setting, it is feasible and safe to rely on LSC as the mainstay surgical procedure for the repair of a significant a-POP. However, it is imperative to ensure that technical skills and equipment requirements are fulfilled and maintained. (C) 2019 Elsevier B.V. All rights reserved.
Název v anglickém jazyce
Laparoscopic sacrocolpopexy as the mainstay management for significant apical pelvic organ prolapse (LAP) study
Popis výsledku anglicky
Study objectives: The primary aim of this study was to assess the clinical feasibility of a policy where laparoscopic sacrocolpopexy (LSC) is the default procedure for the management of a significant apical pelvic organ prolapse (a-POP). As a secondary aim, we wanted to evaluate LSC outcomes in relation to women's preoperative assessment of their surgical fitness using the American Society of Anesthesiologists physical status (ASA-PS) categorization. Design: Retrospective cohort study. Setting: A university affiliated urogynecology center. Methods: All women with symptomatic a-POP (C >= -1) who attended the urogynecology clinic between the 1st of January and the 31st of December 2016 and had their surgery by the 31st of May 2017 were included in the study. In our unit, routine follow-up appointments are arranged at 3 and 12 months post LSC. Interventions: Perioperative and mesh-related complications were assessed based on the Dindo-Clavien and IUGA/ICS classifications respectively. The preoperative outcome measures included Pelvic Organ Prolapse Quantification (POP-Q) stage, Pelvic Floor Distress Inventory (PFDI) and ASA-PS score. At followup women were asked to complete a PFDI, Patient Global Impression of Improvement (PGI-1), had their POP-Qstaging and ultrasonographic assessment of mesh position and placement. The above measures are routinely collected as part of our standard practice. A preoperative ASA-PS score of <3 was used as a cut-off to dichotomies participants into low and high risk. Main results: A total of 220 women attended our center during the study period because of POP. Of these, 146 women were diagnosed with a significant a-POP and 142 (97.2 %) women opted for a surgical repair. Of the 142 women, 128 (90.1 %) were deemed suitable for a type of LSC and 121 had their surgery before the 31st of May 2017. There were no statistically significant differences in any of our collected perioperative, clinical, patient reported or ultrasonographic outcome measures when comparing women with ASA-PS scores of <3 or >= 3. Conclusion: In a specialized urogynecology healthcare setting, it is feasible and safe to rely on LSC as the mainstay surgical procedure for the repair of a significant a-POP. However, it is imperative to ensure that technical skills and equipment requirements are fulfilled and maintained. (C) 2019 Elsevier B.V. All rights reserved.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30214 - Obstetrics and gynaecology
Návaznosti výsledku
Projekt
<a href="/cs/project/LO1503" target="_blank" >LO1503: BIOMEDIC</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
European Journal of Obstetrics & Gynecology and Reproductive Biology
ISSN
0301-2115
e-ISSN
—
Svazek periodika
244
Číslo periodika v rámci svazku
January
Stát vydavatele periodika
IE - Irsko
Počet stran výsledku
6
Strana od-do
60-65
Kód UT WoS článku
000508768900014
EID výsledku v databázi Scopus
2-s2.0-85074938048